These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 18177455

  • 1. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Aug; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J, Torok N.
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C.
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [Abstract] [Full Text] [Related]

  • 7. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 8. Pediatric nonalcoholic fatty liver disease.
    Lerret SM, Skelton JA.
    Gastroenterol Nurs; 2008 Mar; 31(2):115-9. PubMed ID: 18391799
    [Abstract] [Full Text] [Related]

  • 9. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Apr; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 11. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M.
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 13. Recent advances in nonalcoholic fatty liver disease.
    Cheung O, Sanyal AJ.
    Curr Opin Gastroenterol; 2010 May; 26(3):202-8. PubMed ID: 20168226
    [Abstract] [Full Text] [Related]

  • 14. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R, Musso G, Cassader M.
    Antioxid Redox Signal; 2011 Sep 01; 15(5):1325-65. PubMed ID: 20969475
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 16. The treatment of NAFLD.
    Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C.
    Eur Rev Med Pharmacol Sci; 2005 Jul 31; 9(5):299-304. PubMed ID: 16231594
    [Abstract] [Full Text] [Related]

  • 17. Activin A in nonalcoholic fatty liver disease.
    Yndestad A, Haukeland JW, Dahl TB, Halvorsen B, Aukrust P.
    Vitam Horm; 2011 Jul 31; 85():323-42. PubMed ID: 21353887
    [Abstract] [Full Text] [Related]

  • 18. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L, Forgione A, Gasbarrini G, Grieco A.
    Transl Res; 2007 Mar 31; 149(3):114-25. PubMed ID: 17320797
    [Abstract] [Full Text] [Related]

  • 19. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA, Feldstein AE.
    J Dig Dis; 2011 Feb 31; 12(1):10-6. PubMed ID: 21091933
    [Abstract] [Full Text] [Related]

  • 20. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov 31; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.